DRUG ABUSE TREATMENT COSTS OF MEDICAID CLIENTS IN AN HMO

健康维护组织（HMO）注册人数的急剧增长 人们对治疗是否充分表示担忧， 有药物滥用问题的人。这个话题特别 越来越多的国家对现在取代收费的国家感兴趣， 为医疗补助客户提供资本医疗保健系统服务，许多 他们有严重的药物滥用问题如果这是真的， 护理的连续性，并导致医疗补助客户的结果较差， 药物滥用问题 本研究的主要目的是更好地了解 为医疗补助客户提供物质滥用治疗，以改善 照顾医疗补助登记者。具体目标是： 1.描述Medicaid的注册持续时间、服务使用和成本护理 寻求治疗化学品依赖的受资助登记者; 2.比较登记持续时间、服务使用和护理费用， 化学依赖的医疗补助客户与非医疗补助HMO软管 参加者;及 3.开发一个风险调整模型，旨在提高预测 医疗补助人群的化学依赖治疗费用。 决策者可以利用这项研究的信息制定政策， 改善医疗补助客户在HMO中的保留情况， 成员每月支付率资本医疗补助计划。政策 制造商特别需要医疗补助人群的子群体的成本数据 例如儿童和青年。

The dramatic growth in health maintenance organizations (HMO) enrollment has heightened concern about the adequacy of treatment available for persons with substance abuse problems. This topic is of particular interest to the growing number of states that are now replacing fee-for- service with capitated health care systems for Medicaid clients, many of whom have severe substance abuse problems. If true, this could disrupt continuity of care and lead to poorer outcomes for Medicaid clients with substance abuse problems. The broad purpose of this study is to provide a better understanding of substance abuse treatment for Medicaid clients in HMOs in order to improve care for Medicaid enrollees. The specific aims are: 1. To describe enrollment duration, service use, and cost care of Medicaid funded enrollees seeking treatment of chemical dependency; 2. To compare enrollment duration, service use, and cost of care of chemically dependent Medicaid clients with hose of non-Medicaid HMO enrollees; and 3. To develop a risk adjustment model designed to improve the prediction of chemical dependency treatment costs for the Medicaid population. Decision makers could use information from this study to set policies to improve the retention of Medicaid clients in HMOs and for setting per member per month payment rates for capitated Medicaid programs. Policy makers especially need cost data on sub-groups of the Medicaid population such as children and youth.